References
- Temple AR. Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med. 1981;141(3 Spec No):364–369.
- Trinder P. Rapid determination of salicylate in biological fluids.Biochem J. 1954;57(2):301–303.
- Duffens KR, Smilkstein MJ, Bessen HA, et al. Falsely elevated salicylate levels due to diflunisal overdose. J Emerg Med. 1987;5(6):499–503.
- Dasgupta A, Zaidi S, Johnson M, et al. Use of fluorescence polarization immunoassay for salicylate to avoid positive/negative interference by bilirubin in the Trinder salicylate assay. Ann Clin Biochem. 2003;40(Pt 6):684–688.
- You K, Bittikofer JA. Quantification of salicylate in serum by use of salicylate hydroxylase. Clin Chem. 1984;30(9): 1549–1551.
- Baer DM, Paulson RA. The effect of hyperlipidemia on therapeutic drug assays. Ther Drug Monit. 1987;9(1):72–77
- Nikolac N. Lipemia: causes, interference mechanisms, detection and management. Biochem Med (Zagreb). 2014;24(1):57–67. DOI:10.11613/BM.2014.008.
- Charlton NP, Lawrence DT, Wallace KL. Falsely elevated salicylate levels. J Med Toxicol. 2008;4(4):310–311
- Grunbaum AM, Gilfix BM, Hoffman RS, et al. Review of the effect of intravenous lipid emulsion on laboratory analyses. Clin Toxicol (Phila). 2016;54(2):92–102. DOI:10.3109/15563650.2015.1115515.